Efficacy of therapeutic plasma exchange on angiotensin II type‐1 receptor antibodies on two kidney transplant recipients
Chisa Yamada(University of Michigan), Laura Cooling(University of Michigan), Silas P. Norman(University of Michigan), Abhijit S. Naik(University of Michigan), Osama Moussa(University of Michigan), Milagros Samaniego(Henry Ford Health System), Yihung Huang(University of Michigan)
Cited by 10
Related Papers
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193
Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study
|The Lancet|2016|181
A reference tissue atlas for the human kidney
|Science Advances|2022|170